Lodonal and Diabetes and Obesity

Any person with an inflammatory condition like diabetes will have a decreased T4 to T3 conversion in the body and a relative tissue hypothyriodism. The inflammatory cytokines will, however increase the activity of D2 and suppress the TSH despite reduced peripheral T3 levels. Lodonal can make living with Diabetes much more manageable. We know these post can get a little wordy with all the technical terms but if you suffer from one of these illnesses you probably understand. Lodonal and thyroid utilization has big impact on diabetes and weight loss. 

Lodonal is showing ability to improve the transport of thyroid hormones in the cells, increase T4 to T3 conversion and reduce T$ to reverse T3 conversion, Thus, Lodonal can reverse the causes of the thyroid resistance that are shown to be present in the majority of people in the uS and the world. As expected, Lodonal can be beneficial in the team of not only autoimmune diseases, but also depression, insulin resistance, diabetes, obesity, anxiety, neurodegenerative diseases, chronic fatigue syndrome, fibromyalgia, hypercholesterolemia, and other chronic illnesses. The increased thyroid utilization also makes it beneficial for weight loss. (it is an FDA-approved component for weight loss). 

A team over at UC San Diego also has found some promising results with Diabetes and Obesity.  I hope we can all work together to find the best solution to help people in need. "A UC San Diego-led team studying chronic inflammation and Type 2 diabetes has discovered that removing the protein galectin-3 from mice can reverse the insulin resistance and glucose intolerance that come with diabetes and obesity. The team removed galectin-3, or Gal3, from the mice either genetically or by using drugs, according to a statement. They were able to bring insulin sensitivity and glucose tolerance to normal levels, even in older mice. While this finding was encouraging for diabetes symptoms, removing the protein did not affect obesity." - Amriah Al Idrus